Gaitonde E J, Morris A, Sivagnanasundaram S, McKenna P J, Hunt D M, Mollon J D
Department of Experimental Psychology, Cambridge University, United Kingdom.
Am J Med Genet. 1996 Sep 20;67(5):455-8. doi: 10.1002/(SICI)1096-8628(19960920)67:5<455::AID-AJMG3>3.0.CO;2-J.
Several studies have reported an association between schizophrenia and homozygosity for the MscI restriction site in exon 1 of the D3 dopamine receptor gene, but other studies have failed to find this association. Recent reports have suggested that the association is most salient in male patients with a family history of schizophrenia. We examined this restriction site in a group of schizophrenic patients (n = 84) and in normal controls (n = 77). Patients were subdivided according to demographic and clinical features, particular attention being paid to movement disorders. No significant difference in allelic or genotypic distribution was seen between the two groups. No association was seen between homozygosity and a positive family history, age at onset of illness, clinical subtype, negative symptom score, or movement disorder scores.
多项研究报告称,精神分裂症与D3多巴胺受体基因外显子1中MscI限制性位点的纯合性之间存在关联,但其他研究未能发现这种关联。最近的报告表明,这种关联在有精神分裂症家族史的男性患者中最为显著。我们在一组精神分裂症患者(n = 84)和正常对照组(n = 77)中检测了这个限制性位点。根据人口统计学和临床特征对患者进行了细分,特别关注了运动障碍。两组之间在等位基因或基因型分布上没有显著差异。在纯合性与阳性家族史、发病年龄、临床亚型、阴性症状评分或运动障碍评分之间未发现关联。